HEADER PROTEIN BINDING 13-AUG-07 2QY7 TITLE CRYSTAL STRUCTURE OF HUMAN EPSINR ENTH DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: CLATHRIN INTERACTOR 1; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: EPSINR ENTH DOMAIN; COMPND 5 SYNONYM: EPSIN-4, EPSIN-RELATED PROTEIN, EPSINR, ENTHOPROTIN, COMPND 6 CLATHRIN-INTERACTING PROTEIN LOCALIZED IN THE TRANS- GOLGI REGION, COMPND 7 CLINT; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CLINT1, ENTH, EPN4, EPNR, KIAA0171; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS ENTH DOMAIN, EPSIN, ALTERNATIVE SPLICING, CYTOPLASM, CYTOPLASMIC KEYWDS 2 VESICLE, ENDOCYTOSIS, LIPID-BINDING, MEMBRANE, PHOSPHORYLATION, KEYWDS 3 PROTEIN BINDING EXPDTA X-RAY DIFFRACTION AUTHOR S.E.MILLER,B.M.COLLINS,A.J.MCCOY,M.S.ROBINSON,D.J.OWEN REVDAT 3 21-FEB-24 2QY7 1 REMARK REVDAT 2 24-FEB-09 2QY7 1 VERSN REVDAT 1 27-NOV-07 2QY7 0 JRNL AUTH S.E.MILLER,B.M.COLLINS,A.J.MCCOY,M.S.ROBINSON,D.J.OWEN JRNL TITL A SNARE-ADAPTOR INTERACTION IS A NEW MODE OF CARGO JRNL TITL 2 RECOGNITION IN CLATHRIN-COATED VESICLES. JRNL REF NATURE V. 450 570 2007 JRNL REFN ISSN 0028-0836 JRNL PMID 18033301 JRNL DOI 10.1038/NATURE06353 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.35 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 27096 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1439 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1928 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.82 REMARK 3 BIN R VALUE (WORKING SET) : 0.2190 REMARK 3 BIN FREE R VALUE SET COUNT : 111 REMARK 3 BIN FREE R VALUE : 0.2730 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3426 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 321 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.05 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.04000 REMARK 3 B22 (A**2) : 0.06000 REMARK 3 B33 (A**2) : -0.08000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.10000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.230 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.193 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.124 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.263 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.937 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.902 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3489 ; 0.010 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4674 ; 1.169 ; 1.953 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 405 ; 5.475 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 195 ;34.205 ;23.846 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 693 ;16.653 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 36 ;20.466 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 477 ; 0.089 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2652 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1835 ; 0.210 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2364 ; 0.294 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 290 ; 0.166 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 116 ; 0.223 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 47 ; 0.142 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2111 ; 0.870 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3255 ; 1.385 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1596 ; 2.066 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1419 ; 3.362 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2QY7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-AUG-07. REMARK 100 THE DEPOSITION ID IS D_1000044193. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9816 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28679 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 36.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 4.400 REMARK 200 R MERGE (I) : 0.11200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.10 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.3 REMARK 200 DATA REDUNDANCY IN SHELL : 4.30 REMARK 200 R MERGE FOR SHELL (I) : 0.38900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.86 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.05 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% (W/V) PEG3000, 100 MM CHES, PH REMARK 280 9.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 45.56100 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 156 REMARK 465 ASP A 157 REMARK 465 LYS A 158 REMARK 465 TYR A 159 REMARK 465 VAL A 160 REMARK 465 GLY A 161 REMARK 465 VAL A 162 REMARK 465 SER A 163 REMARK 465 SER A 164 REMARK 465 ASP A 165 REMARK 465 SER A 166 REMARK 465 LYS B 156 REMARK 465 ASP B 157 REMARK 465 LYS B 158 REMARK 465 TYR B 159 REMARK 465 VAL B 160 REMARK 465 GLY B 161 REMARK 465 VAL B 162 REMARK 465 SER B 163 REMARK 465 SER B 164 REMARK 465 ASP B 165 REMARK 465 SER B 166 REMARK 465 LYS C 156 REMARK 465 ASP C 157 REMARK 465 LYS C 158 REMARK 465 TYR C 159 REMARK 465 VAL C 160 REMARK 465 GLY C 161 REMARK 465 VAL C 162 REMARK 465 SER C 163 REMARK 465 SER C 164 REMARK 465 ASP C 165 REMARK 465 SER C 166 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NZ LYS C 151 O HOH C 200 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE2 GLU A 147 O GLU C 95 1556 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 36 40.30 -73.77 REMARK 500 HIS A 120 40.77 85.77 REMARK 500 PRO B 36 26.59 -70.79 REMARK 500 ASP B 71 60.66 39.40 REMARK 500 ASN B 75 72.25 -109.19 REMARK 500 PRO C 36 43.64 -74.27 REMARK 500 LYS C 154 -79.15 -79.02 REMARK 500 REMARK 500 REMARK: NULL DBREF 2QY7 A 20 166 UNP Q14677 EPN4_HUMAN 20 166 DBREF 2QY7 B 20 166 UNP Q14677 EPN4_HUMAN 20 166 DBREF 2QY7 C 20 166 UNP Q14677 EPN4_HUMAN 20 166 SEQRES 1 A 147 ASN TYR SER GLU ILE GLU SER LYS VAL ARG GLU ALA THR SEQRES 2 A 147 ASN ASP ASP PRO TRP GLY PRO SER GLY GLN LEU MET GLY SEQRES 3 A 147 GLU ILE ALA LYS ALA THR PHE MET TYR GLU GLN PHE PRO SEQRES 4 A 147 GLU LEU MET ASN MET LEU TRP SER ARG MET LEU LYS ASP SEQRES 5 A 147 ASN LYS LYS ASN TRP ARG ARG VAL TYR LYS SER LEU LEU SEQRES 6 A 147 LEU LEU ALA TYR LEU ILE ARG ASN GLY SER GLU ARG VAL SEQRES 7 A 147 VAL THR SER ALA ARG GLU HIS ILE TYR ASP LEU ARG SER SEQRES 8 A 147 LEU GLU ASN TYR HIS PHE VAL ASP GLU HIS GLY LYS ASP SEQRES 9 A 147 GLN GLY ILE ASN ILE ARG GLN LYS VAL LYS GLU LEU VAL SEQRES 10 A 147 GLU PHE ALA GLN ASP ASP ASP ARG LEU ARG GLU GLU ARG SEQRES 11 A 147 LYS LYS ALA LYS LYS ASN LYS ASP LYS TYR VAL GLY VAL SEQRES 12 A 147 SER SER ASP SER SEQRES 1 B 147 ASN TYR SER GLU ILE GLU SER LYS VAL ARG GLU ALA THR SEQRES 2 B 147 ASN ASP ASP PRO TRP GLY PRO SER GLY GLN LEU MET GLY SEQRES 3 B 147 GLU ILE ALA LYS ALA THR PHE MET TYR GLU GLN PHE PRO SEQRES 4 B 147 GLU LEU MET ASN MET LEU TRP SER ARG MET LEU LYS ASP SEQRES 5 B 147 ASN LYS LYS ASN TRP ARG ARG VAL TYR LYS SER LEU LEU SEQRES 6 B 147 LEU LEU ALA TYR LEU ILE ARG ASN GLY SER GLU ARG VAL SEQRES 7 B 147 VAL THR SER ALA ARG GLU HIS ILE TYR ASP LEU ARG SER SEQRES 8 B 147 LEU GLU ASN TYR HIS PHE VAL ASP GLU HIS GLY LYS ASP SEQRES 9 B 147 GLN GLY ILE ASN ILE ARG GLN LYS VAL LYS GLU LEU VAL SEQRES 10 B 147 GLU PHE ALA GLN ASP ASP ASP ARG LEU ARG GLU GLU ARG SEQRES 11 B 147 LYS LYS ALA LYS LYS ASN LYS ASP LYS TYR VAL GLY VAL SEQRES 12 B 147 SER SER ASP SER SEQRES 1 C 147 ASN TYR SER GLU ILE GLU SER LYS VAL ARG GLU ALA THR SEQRES 2 C 147 ASN ASP ASP PRO TRP GLY PRO SER GLY GLN LEU MET GLY SEQRES 3 C 147 GLU ILE ALA LYS ALA THR PHE MET TYR GLU GLN PHE PRO SEQRES 4 C 147 GLU LEU MET ASN MET LEU TRP SER ARG MET LEU LYS ASP SEQRES 5 C 147 ASN LYS LYS ASN TRP ARG ARG VAL TYR LYS SER LEU LEU SEQRES 6 C 147 LEU LEU ALA TYR LEU ILE ARG ASN GLY SER GLU ARG VAL SEQRES 7 C 147 VAL THR SER ALA ARG GLU HIS ILE TYR ASP LEU ARG SER SEQRES 8 C 147 LEU GLU ASN TYR HIS PHE VAL ASP GLU HIS GLY LYS ASP SEQRES 9 C 147 GLN GLY ILE ASN ILE ARG GLN LYS VAL LYS GLU LEU VAL SEQRES 10 C 147 GLU PHE ALA GLN ASP ASP ASP ARG LEU ARG GLU GLU ARG SEQRES 11 C 147 LYS LYS ALA LYS LYS ASN LYS ASP LYS TYR VAL GLY VAL SEQRES 12 C 147 SER SER ASP SER FORMUL 4 HOH *321(H2 O) HELIX 1 1 SER A 22 THR A 32 1 11 HELIX 2 2 SER A 40 PHE A 52 1 13 HELIX 3 3 GLN A 56 LYS A 70 1 15 HELIX 4 4 ASN A 75 GLY A 93 1 19 HELIX 5 5 SER A 94 HIS A 104 1 11 HELIX 6 6 HIS A 104 SER A 110 1 7 HELIX 7 7 LEU A 111 TYR A 114 5 4 HELIX 8 8 GLN A 124 ASP A 141 1 18 HELIX 9 9 ASP A 141 ASN A 155 1 15 HELIX 10 10 SER B 22 THR B 32 1 11 HELIX 11 11 SER B 40 THR B 51 1 12 HELIX 12 12 GLN B 56 LYS B 70 1 15 HELIX 13 13 ASN B 75 GLY B 93 1 19 HELIX 14 14 SER B 94 HIS B 104 1 11 HELIX 15 15 HIS B 104 SER B 110 1 7 HELIX 16 16 GLN B 124 ASP B 141 1 18 HELIX 17 17 ASP B 141 ASN B 155 1 15 HELIX 18 18 SER C 22 THR C 32 1 11 HELIX 19 19 SER C 40 THR C 51 1 12 HELIX 20 20 GLN C 56 LYS C 70 1 15 HELIX 21 21 ASN C 75 GLY C 93 1 19 HELIX 22 22 SER C 94 HIS C 104 1 11 HELIX 23 23 HIS C 104 SER C 110 1 7 HELIX 24 24 GLN C 124 GLN C 140 1 17 HELIX 25 25 ASP C 141 ASN C 155 1 15 CISPEP 1 GLY A 38 PRO A 39 0 0.46 CISPEP 2 GLY B 38 PRO B 39 0 8.20 CISPEP 3 GLY C 38 PRO C 39 0 -1.19 CRYST1 46.455 91.122 52.893 90.00 107.13 90.00 P 1 21 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021526 0.000000 0.006633 0.00000 SCALE2 0.000000 0.010974 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019783 0.00000